PExA AB is a Sweden-based company engaged in the advanced equipment and technology industry. The Company develops, manufactures and markets a non-invasive research instrument to study respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). The instrument provides lung researchers with a non-invasive method for collecting microscopic particles, potential biomarkers for diseases, from small airways in exhaled air to diagnose, monitor and provide treatment of respiratory diseases.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change
06/10/26	€0.0224	0.00%
05/10/26	€0.0224	0.00%
02/10/26	€0.0224	-6.67%
01/10/26	€0.0240	+11.11%
30/09/26	€0.0216	0.00%

Delayed Quote Deutsche Boerse AG

More quotes

Delayed Deutsche Boerse AG 14:25:01 06/10/2026 BST			5-day change	1st Jan Change
0.0224 ^EUR	0.00%		+3.70%	+49.33%

09-29	Pexa saw strong interest at the ERS lung congress	FW
09-03	Pexa technology featured in three research presentations at pulmonary congress	FW

Market Cap	27.06M 2.71M 2.41M 2.25M 2.04M 3.86M 261M 3.88M 10.53M 133M 10.18M 9.96M 429M	P/E 2023	-2.18x	P/E 2024	-1.13x
Enterprise Value	21.47M 2.15M 1.91M 1.79M 1.62M 3.06M 207M 3.08M 8.35M 106M 8.08M 7.9M 340M	EV / Sales 2023	3.92x	EV / Sales 2024	8.49x
Free-Float	-	Yield 2023 *	-	Yield 2024	-

Markets		Quality
SPOTLIGHT STOCK MARKET AB	PEXA B	End-of-day quote
Deutsche Boerse AG	FA0	Delayed

09-29	Pexa saw strong interest at the ERS lung congress	FW
09-03	Pexa technology featured in three research presentations at pulmonary congress	FW
08-28	Pexa reports modest performance shifts, CEO: new capital provides substantially greater flexibility	FW
08-28	PExA AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-20	Pexa's directed share issue registered after positive decision from ISP	FW
08-19	Pexa technology draws attention after silicosis study in Australia	FW
07-28	Pexa's rights issue was oversubscribed	FW
07-13	Pexa - Interview with CEO Tomas Gustafsson	FW
07-10	Pexa raises SEK10m in a directed share issue, Anders Hallberg becomes a major shareholder	FW
07-01	Pexa raises nearly 10 million kronor in fully guaranteed rights issue	FW
06-23	Pexa signs a SEK 7.5m contract with a global pharmaceutical company	FW
06-10	Pexa secures order from the US	FW
06-02	Doctoral thesis presents findings from studies using Pexa technology	FW

PExA AB Share Price Deutsche Boerse AG

Stocks

FA0

SE0007412374

Advanced Medical Equipment & Technology

Valuation: PExA AB

Chart: PExA AB

Latest news: PExA AB

Analysts' recommendations: PExA AB

Press Releases: PExA AB

Quotes and Performance

Price Extremes

Managers and Directors: PExA AB

Medical Diagnostic & Testing Equipment

Financials

Company Profile

Quotes

11-07	Pexa - Q3 Presentation 2025	FW
11-07	Pexa Reports Minor Earnings Changes as Company Advances Toward Diagnostic Applications	FW

09-03	PExA : at the world’s largest respiratory congress – three accepted abstracts featuring PExA to be presented	PU
06-23	PExA : signs agreement with global pharmaceutical company for 10 instruments for clinical multicenter study in pulmonary fibrosis, with a value of approximately SEK 7.5 million	PU
06-10	PExA : U.S. government agency customer orders upgrade of existing PExA system	PU
06-02	PExA : New doctoral thesis strengthens PExA’s opportunities in lung cancer and other lung diseases	PU
05-13	PExA : partner in Dutch precision medicine project within COPD and interstitial lung diseases	PU

1 week	+3.70%
Current month	+3.70%
1 month	-8.20%
3 months	-33.73%
6 months	+72.31%
Current year	+49.33%

1 week	0.02	0.02
1 month	0.02	0.03
Current year	0.01	0.1
1 year	0.01	0.1
3 years	0.01	0.1
5 years	0.01	0.1
10 years	0.01	0.1

Manager	Title	Age	Since
Bengt Tomas Jan Gustafsson CEO	Chief Executive Officer	55	-
Jörgen Östling CTO	Chief Tech/Sci/R&D Officer	-	31/12/2017
Svante Höjer CTO	Chief Tech/Sci/R&D Officer	65	31/12/2014

Director	Title	Age	Since
Anna-Carin Olin BRD	Director/Board Member	66	31/12/2009
Claes Frederik Holmberg CHM	Chairman	72	30/01/2014
Björn Lennart Dahlöf BRD	Director/Board Member	73	31/12/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PEXA AB	0.00%	+3.70%	-	-	3.92M
THERMO FISHER SCIENTIFIC, INC.	-2.98%	-3.39%	+20.71%	+31.70%	243B
DANAHER CORPORATION	-2.53%	-4.64%	+1.84%	-0.75%	152B
INTUITIVE SURGICAL, INC.	-0.42%	-1.80%	-9.99%	+36.89%	143B
BOSTON SCIENTIFIC CORPORATION	-0.50%	-3.85%	-56.37%	-19.05%	61.14B
EDWARDS LIFESCIENCES CORPORATION	-0.86%	-1.82%	+12.96%	+17.34%	49.85B
AGILENT TECHNOLOGIES, INC.	-1.00%	-3.26%	+19.57%	+53.05%	47.74B
SIEMENS HEALTHINEERS AG	+0.33%	-1.50%	-21.21%	-19.75%	47.74B
VEEVA SYSTEMS INC.	+0.02%	+1.77%	-5.42%	+35.26%	45.9B
ILLUMINA, INC.	-6.86%	+0.57%	+170.78%	+95.36%	41.3B
Average	-1.48%	-1.17%	+14.76%	+25.56%	92.33B
Weighted average by Cap.	-1.87%	-1.28%	+9.39%	+23.71%

	2023	2024
Net sales	2.02M 202K 179K 168K 152K 287K 19.47M 289K 784K 9.93M 758K 742K 31.93M	720K 72.13K 64.03K 59.92K 54.31K 103K 6.95M 103K 280K 3.55M 271K 265K 11.4M
Net income	-8.04M -806K -716K -670K -607K -1.15M -77.72M -1.15M -3.13M -39.65M -3.03M -2.96M -127M	-10.16M -1.02M -904K -846K -767K -1.45M -98.19M -1.46M -3.95M -50.09M -3.82M -3.74M -161M
Net Debt	-9.6M -962K -854K -799K -724K -1.37M -92.75M -1.38M -3.73M -47.32M -3.61M -3.53M -152M	-5.59M -561K -498K -466K -422K -797K -54.04M -803K -2.18M -27.57M -2.1M -2.06M -88.63M